Login
Navigate Fool.com
Will CUR beat
the market?

Neuralstem Inc.

NYSEMKT: CUR

Community Rating: 3 Stars: Appealing

1.41 -0.02 (-1.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.44
Previous Close $1.43
Daily Range $1.40 - $1.45
52-Week Range $0.42 - $1.96
Market Cap $97.0M
P/E Ratio -8.41
Dividend (Yield) $0.00 (0.0%)
Volume 37,519
Average Daily Volume 604,412
Current FY EPS -$0.16

How do you think CUR
will perform against the market?

Top CUR Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted February 24, 2011

Despite their precarious financial position the one year low for Neuralstem is 1.8. I'm going to try and jump in for a quick rebound on a volatile stock, but if I get caught in the dilution downdraft … More

0 Replies Reply Report this Post
 

geneticbiscuit (< 20)
Submitted May 4, 2010

Probably a bit early on this underperform call, but this recent run on news of entering Phase I trials for their stem cell treatments for ALS is a bit ridiculous.<br />With less than 5 million in the … More

0 Replies Reply Report this Post

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.

FDA OKs Neuralstem Trial Treating Spinal Cord Injuries With Stem Cells

NSI-566 has already shown promise in ALS and rat models of spinal cord injuries.

BRIEF-Neuralstem jumps in premarket after FDA OK's spinal cord injury trial

Josh Levine Names Three Biotech Game-Changers

CAPScall of the Week: Neuralstem

A weekly adventure in giving unknown companies some attention.

3 Stocks to Get on Your Watchlist

Stocks to watch Monday: LDK, OfficeMax

Today’s Market Winners and Losers

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

See More CUR News...

Sector

Healthcare

Industry

Drugs

Neuralstem Inc. (CUR) Description

Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine. Website: http://www.neuralstem.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks